Yantai Dongcheng Pharmaceutical Group Co.,Ltd.
002675.SZ · SHZ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | CN¥3 | CN¥3 | CN¥4 | CN¥4 |
| % Growth | -12.4% | -8.6% | -8.4% | – |
| Cost of Goods Sold | CN¥2 | CN¥2 | CN¥2 | CN¥2 |
| Gross Profit | CN¥1 | CN¥1 | CN¥2 | CN¥2 |
| % Margin | 47% | 41.3% | 42.8% | 40.6% |
| R&D Expenses | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| G&A Expenses | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| SG&A Expenses | CN¥1 | CN¥1 | CN¥1 | CN¥1 |
| Sales & Mktg Exp. | CN¥0 | CN¥1 | CN¥1 | CN¥1 |
| Other Operating Expenses | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Operating Expenses | CN¥1 | CN¥1 | CN¥1 | CN¥1 |
| Operating Income | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| % Margin | 7.7% | 10.4% | 12.5% | 9.1% |
| Other Income/Exp. Net | -CN¥0 | -CN¥0 | -CN¥0 | -CN¥0 |
| Pre-Tax Income | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Tax Expense | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Net Income | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| % Margin | 6.4% | 6.4% | 8.6% | 3.9% |
| EPS | 0.223 | 0.254 | 0.38 | 0.189 |
| % Growth | -12.4% | -33.1% | 101.2% | – |
| EPS Diluted | 0.223 | 0.254 | 0.38 | 0.189 |
| Weighted Avg Shares Out | 1 | 1 | 1 | 1 |
| Weighted Avg Shares Out Dil | 1 | 1 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Interest Expense | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Depreciation & Amortization | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| EBITDA | CN¥0 | CN¥1 | CN¥1 | CN¥1 |
| % Margin | 15.1% | 15.6% | 18.8% | 18.6% |